PRESS PLAY AND THANK YOU FOR TUNING IN.
MODERATOR & PANELISTS
This symposium’s panelists are recognized leaders on the cutting edge of behavioral health care delivery, and advocates for exploring new approaches to treatment. As we raise awareness and break down stigma, we hope people needing treatment will be more likely to seek help and barriers to treatment will subside, freeing the flow of services to those in need.
Moderator and Speaker: Steven Adelsheim, M.D.
Topic: Suicide prevention, early psychosis program development, expanded school mental health work, Headspace Program
Dr. Adelsheim is a Clinical Professor of Psychiatry and Behavioral Sciences at Stanford University, the Director of Community Partnerships for the Department of Psychiatry and Behavioral Sciences, and the Director of the Stanford Center for Youth Mental Health and Wellbeing. Dr. Adelsheim is a national leader in developing and implementing early detection and intervention programs for young people in school-based and primary care settings, including programs for depression, anxiety, and prodromal symptoms as well as first episodes of psychosis. Dr. Adelsheim also develops statewide mental health policy and systems focused on bettering and expanding school mental health and suicide prevention, such as spearheading the implementation of the Headspace Program in the United States after successful program outcomes in Australia. Additionally, Dr. Adelsheim is involved in integrating behavioral and primary care health and the use of media to decrease mental health stigma.
For more information, see: https://med.stanford.edu/profiles/steven-adelsheim
Speaker: Leanne Williams, Ph.D.
Topic: Depression, anxiety, and finding tests that help match individuals with the best treatment
Brief biography: Dr. Williams is a Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, the Director of PanLab, and the Director of PTSD Education at Palo Alto Sierra-Pacific MIRECC, an integrated system of clinical care for veterans with dementia and PTSD. Dr. Williams’s research programs are aimed at changing how we characterize people experiencing mental disorders such as depression and anxiety. She deconstructs diagnostic groups using brain imaging, physiological, behavioral and genetic data. Her goal is to characterize dysfunction at the individual person level and to identify biomarkers that will guide prognostic and treatment decisions in real world clinical settings. Her research has contributed over 240 publications to the field and attracted multiple awards.
For more information, see: Leanne Williams, PhD
Speaker: Karan Singh, MS, MBA
Topic: Technology in Behavioral Healthcare Delivery
Brief biography: Mr. Singh is the Co-Founder at Ginger.io, a technology-enabled mental health provider for people with depression and anxiety. Karan currently leads Ginger.io’s clinical operations and strategy. He has extensive experience across the healthcare ecosystem working in management consulting, data analytics, and emerging markets. A leader in the digital health community, Karan is a frequent speaker on the topics of entrepreneurship, healthcare innovation and new models of mental health treatment and delivery. He holds his MBA from the Massachusetts Institute of Technology (MIT) Sloan with a fellowship in entrepreneurship from the Legatum Center for Development, and he is currently on hiatus from Harvard Medical School. Karan received his BA and BS in Economics and Business Administration from UC Berkeley.
For more information, see: https://ginger.io/about/
Speaker: Stephan Sanders, BMBS, Ph.D.
Topic: Autism, early detection of Schizophrenia, and recent findings on genetic linkage between Schizophrenia and Autism.
Brief Biography: Dr. Sanders is an Assistant Professor in the Department of Psychiatry at UCSF School of Medicine. Dr. Sanders trained as a pediatric physician at Nottingham and London in the UK, receiving his Bachelor of Surgery at Nottingham University Medical School in 2003. He then completed his Ph.D. at Yale in 2014 and took a postdoctoral research position at Yale focusing on using genomics and bioinformatics to understand the etiology of human disease, especially Autism Spectrum Disorder (ASD). Dr. Sander’s research has been used to identify multiple ASD genes and is now being used to investigate what these genes reveal about ASD neuropathology to understand the cause of autism.
For more information, see: http://profiles.ucsf.edu/stephan.sanders
4:30 PM Gardens open for self-guided tours. Enjoy refreshments and hors d’oeuvres
6:00 PM Presentation space opens. Gather and network with colleagues and friends
6:30 PM All guests seated. Welcome by Chip Huggins, Chief Executive Officer.
Premiere of new Caminar Overview Video. Introduction by Dr. Jake Treskovich, Caminar Medical Director
6:45 PM Presentations begin. Each speaker will present for approximately 20 minutes
7:25 PM Ten minute break
7:35 PM Presentations resume
8:20 PM Question and answer session
9:00 PM Clos
Filoli Gardens in Woodside, California is one of the finest remaining country estates of the early 20th century, and is an historic site of the National Trust for Historic Preservation. Our guests will have exclusive, after-hours access to the property beginning at 4:30 PM to enjoy the extensive plant collections and explore the Filoli House designed by Willis Polk. Filoli provides a beautiful setting where guests can enjoy beverages and heavy hors-d’oeuvres, and participate in this important conversation about mental illness.
Mental Illness – a topic long misunderstood by the public and shrouded in stereotype and stigma – is entering a new era of understanding. Caminar believes our society is on the threshold of embracing a healthier and more positive view of mental illness, and we are committed to catalyzing this movement. With our extensive experience in the field and broad network of collaborative partners, Caminar is ideally positioned to lead the local discussion on mental illness, healing, and wellness.
The media spotlight on mental illness, new advances in treatment, and sea-changes in the public’s understanding of mental disorders create a prime opportunity to bring experts into the local conversation. We believe this event will inspire other local and regional responses to the challenges of treating mental illness, and we urge you to get involved by joining our carefully selected group of advocates for the advancement of mental health in the Bay Area. We sincerely hope you will join us in this endeavor.